BSE filing, NSE: UNJHAFOR. Summary written from the filing by ALFA Finder's alert engine.
Unjha Formulations Ltd: key numbers
- Share price
- ₹26.99
- Market cap
- ₹12.09 Cr
- Revenue (annual)
- ₹15.59 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 25.6×Sector 46.5×
- Promoter holding
- 36.92%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unjha Formulations Ltd
All →Unjha Formulations Board Meeting Date
Unjha Formulations intimated BSE of a board meeting on 05/11/2026. It will consider un-audited half-year and quarter results ended 30.09.2026.
Unjha Formulations Other Announcement
Unjha Formulations filed its Regulatory 40(9) compliance certificate for the half-year ended 30.09.2026. The practicing company secretary confirmed timely share-certificate issuance.
Unjha Formulations Financial Results
Unjha Formulations filed the XBRL/XML financial statements for year ended 31/03/2026 with BSE. The submission includes Balance Sheet, P&L, and Cash Flow under SEBI LODR.
Unjha Formulations Other Announcement
Unjha Formulations Limited filed its shareholding distribution schedule as of March 31, 2026, pursuant to SEBI regulations. This is a routine compliance disclosure regarding shareholder distribution.
Unjha Formulations Annual General Meeting
Unjha Formulations Limited conducted its 32nd Annual General Meeting on August 14, 2026. Members transacted business including the adoption of financial statements and director appointments.
Unjha Formulations Annual General Meeting
Unjha Formulations Limited has scheduled its Annual General Meeting for August 14, 2026. Agenda items include the adoption of financial statements and related party transactions worth ₹2.00 Crore.
- Value
- ₹2.00 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.